| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
22,857 |
19,391 |
$2.59M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,066 |
8,593 |
$742K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,480 |
7,783 |
$445K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,466 |
1,455 |
$153K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,059 |
1,055 |
$105K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
921 |
891 |
$94K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,715 |
4,682 |
$64K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
434 |
430 |
$46K |
| 90461 |
|
527 |
526 |
$10K |
| 96127 |
|
840 |
815 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
250 |
241 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
289 |
278 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
121 |
109 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
48 |
48 |
$1K |
| 85018 |
|
372 |
371 |
$896.68 |
| 81003 |
|
219 |
203 |
$487.77 |
| 90686 |
|
856 |
856 |
$91.16 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
27 |
26 |
$54.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
29 |
28 |
$25.00 |
| 90656 |
|
34 |
34 |
$17.00 |
| 90651 |
|
12 |
12 |
$0.01 |
| 90670 |
|
12 |
12 |
$0.00 |
| 90677 |
|
14 |
12 |
$0.00 |